Dr. Lal Path Labs Ltd. has informed the Exchange regarding 'dispatch of letter containing web-link and exact path, where the Annual Report for the FY 2024-25 can be accessed'.
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has informed the stock exchanges that it has dispatched letters to shareholders whose email IDs are not registered with the company, its Registrar & Transfer Agent, or Depository Participants. These letters provide the web-link and exact path where the Annual Report for FY 2024-25 can be accessed, as required under SEBI's Regulation 36(1)(b) of the LODR Regulations, 2015. The 31st Annual General Meeting of the company is scheduled for Saturday, June 28, 2025, at 10:00 AM via video conferencing. The cut-off date for identifying such members was May 30, 2025, and the annual report is hosted at media.lalpathlabs.com as a PDF document. The filing was signed by Vinay Gujral, Company Secretary & Compliance Officer.
This is a routine regulatory compliance disclosure with no material impact on the business or stock price. It simply ensures that all shareholders, including those without registered email addresses, can access the FY 2024-25 Annual Report ahead of the upcoming AGM.